Adenoviral gene transfer of an NF-κB super-repressor increases collagen deposition in rodent cutaneous wound healing

Surgery

Volumn 138, Issue 5, 2005, Pages 940-946

  Schreiber, Jeffrey ^a   Efron, Philip A ^b   Park, Julie E ^a   Moldawer, Lyle L ^b   Barbul, Adrian ^a,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c SINAI HOSPITAL OF BALTIMORE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GREEN FLUORESCENT PROTEIN; HYDROXYPROLINE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRATE; NITRITE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE TRANSFER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; SKIN INFLAMMATION; WOUND HEALING;

ADENOVIRIDAE; ANIMALS; COLLAGEN; DERMATITIS; GENE THERAPY; GENE TRANSFER TECHNIQUES; NF-KAPPA B; NITRATES; NITRITES; RATS; RATS, SPRAGUE-DAWLEY; SKIN; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 27744601774     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2005.05.020     Document Type: Article

References (54)

1. R. Sen, and D. Baltimore Multiple nuclear factors interact with the immunoglobulin enhancer sequences Cell 46 1986 705 716
2. P. Baeuerle The inducible transcriptional activator NF-κB: regulation by distinct protein subunits Biochim Biophys Acta 1072 1991 63 80
3. M. Grilli, J. Chin, and M. Lenardo NF-κB and Rel: participants in a multiform transcriptional regulatory system Int Rev Cytol 143 1993 1 62
4. U. Siebenlist, G. Franzosos, and K. Brown Structure, regulation, and function of NF-κB Annu Rev Cell Biol 10 1994 405 455
5. I. Alkalay, A. Yaron, and A. Hatzubai In vivo stimulation of I-κB phosphorylation is not sufficient to activate NF-κB Mol Cell Biol 15 1995 1294 1301
6. J. DiDonato, F. Mercurio, and M. Karin Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB Mol Cell Biol 15 1995 1302 1311
7. T. Finco, A. Beg, and A. Baldwin Jr. Inducible phosphorylation of IκBα is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors Proc Natl Acad Sci U S A 91 1994 11884 11888
8. Y. Lin, K. Brown, and U. Siebenlist Activation of NF-κB requires proteolysis of the inhibitor IκBα: signal-induced phosphorylation of IκBα alone does not release active NF-κB Proc Natl Acad Sci U S A 92 1995 3003 3009
9. S. Miyamoto, M. Maki, M. Schmitt, M. Hatanaka, and I.M. Verma Tumor necrosis factor α-induced phosphorylation of IκBα is a signal for its degradation but not dissociation from NF-κB Proc Natl Acad Sci 91 1994 12740 12744
10. E. Traenckner, S. Wilk, and P. Baeuerle A proteosome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκBα that is still bound to NF-κB EMBO J 13 1994 5433 5441
11. E.B. Kopp, and S. Ghosh NF-κB and rel proteins in innate immunity Adv Immunol 58 1995 1 27
12. U. Siebenlist, G. Franzoso, and K. Brown Structure, regulation and function of NF-κB Annu Rev Cell Biol 10 1994 45 55
13. P.A. Baeuerle, and D. Baltimore NF-κB: ten years after Cell 87 1996 13 20
14. A.S. Baldwin Jr. The NF-κB and IκB proteins: new discoveries and insights Annu Rev Immunol 14 1996 649 683
15. J. DiDonato, F. Mercurio, and C. Rosette Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation Mol Cell Biol 16 1996 1295 1304
16. Z.J. Chen, L. Parent, and T. Maniatis Site-specific phosphorylation of IκB-α by a novel ubiquitination-dependent protein kinase activity Cell 84 1996 853 862
17. D. Rachmilewitz, J.S. Stamler, and D. Bachwich Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease Gut 36 1995 718 723
18. Q. Hamid, D.R. Springall, and V. Riveros-Moreno Induction of nitric oxide synthase in asthma Lancet 342 1993 1510 1513
19. C.H. Evans, M. Stefanovic-Racic, and J. Lancaster Nitric oxide and its role in orthopaedic disease Clin Orthop 312 1995 275 294
20. P.J. Barnes, and I. Adcock Anti-inflammatory actions of steroids: molecular mechanisms Trends Pharmacol Sci 14 1993 436 441
21. F. Saatcioglu, F.X. Claret, and M. Karin Negative transcriptional regulation by nuclear receptors Semin Cancer Biol 5 1994 347 359
22. R. Schreck, P. Rieber, and P.A. Baeuerle Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1 EMBO J 10 1991 2247 2258
23. J.P. Yang, J.P. Merin, T. Nakano, T. Kato, Y. Kitade, and T. Okamoto Inhibition of the DNA-binding activity of NF-κB by gold compounds in vitro FEBS Lett 361 1995 89 96
24. P. Wang, P. Wu, M.I. Siegel, R.W. Egan, and M.M. Billah Interleukin (IL)-10 inhibits nuclear factor kappa B (NF-κB) activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms J Biol Chem 270 1995 9558 9563
25. C.J. Wrighton, R. Hofer-Warbinek, T. Moll, R. Eytner, F.H. Bach, and R. de Martin Inhibition of endothelial cell activation by adenovirus-mediated expression of IκB-α, an inhibitor of the transcription factor NF-KB J Exp Med 183 1996 1013 1022
26. X. Guirao, and S.F. Lowry Biologic control of injury and inflammation: much more than too little or too late World J Surg 20 1996 437 446
27. R. Minter, J. Rectenwald, and K. Fukuzuka TNF-alpha receptor signaling and IL-10 gene therapy regulate the innate and humoral immune responses to recombinant adenovirus in the lung J Immunol 164 2000 443 451
28. F. Graham, and L. Prevec Methods for construction of adenovirus vectors Mol Biotechnol 3 1995 207 220
29. A. Bett, W. Haddara, L. Prevec, and F. Graham An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3 Proc Natl Acad Sci 91 1994 8802 8806
30. R.M. Minter, J.E. Rectenwald, and K. Fukuzuka TNF-alpha receptor signaling and IL-10 gene therapy regulate the innate and humoral immune responses to recombinant adenovirus in the lung J Immunol 164 2000 443 451
31. D.T. Efron, D. Most, H.P. Shi, U.S. Tantry, and A. Barbul A novel method of studying wound healing J Surg Res 98 2001 16 20
32. J. Safi Jr., A.F. DiPaula Jr., and T. Riccioni Adenovirus-mediated acidic fibroblast growth factor gene transfer induces angiogenesis in the nonischemic rabbit heart Microvasc Res 58 1999 238 249
33. E. Nozato, M. Shiraishi, and T. Nishimaki Up-regulation of hepatocyte growth factor caused by an over-expression of transforming growth factor beta, in the rat model of fulminant hepatic failure J Surg Res 115 2003 226 234
34. J.R. Davis, R.F. McMahon, P.R. Lowenstein, M.G. Castro, G.A. Lincoln, and A.S. McNeilly Adenovirus-mediated gene transfer in the ovine pituitary gland is associated with hypophysitis J Endocrinol 173 2002 265 271
35. J.F. Woessner Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid Arch Biochem Biophys 93 1961 440 447
36. Y. Vodovotz Modified microassay for serum nitrite and nitrate Biotechniques 20 1996 390 394
37. T. Espevik, and J. Nissen-Meyer A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes J Immunol Methods 95 1986 99 105
38. E. Dejardin, G. Bonizzi, A. Bellachene, V. Castronovo, M.P. Merville, and V. Bours Highly-expressed p100/p52 (NFKB2) sequesters other NF-KB-related proteins in the cytoplasm of human breast cancer cells Oncogene 11 1995 1835 1841
39. T.A. Wilgus, Y. Vodovotz, E. Vittadini, E.A. Clubbs, and T.M. Oberyszyn Reduction of scar formation in full-thickness wounds with topical celecoxib treatment Wound Repair Regen 11 2003 25 34
40. G.S. Ashcroft, T. Greenwell-Wild, M.A. Horan, S.M. Wahl, and M.W. Ferguson Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response Am J Pathol 155 1999 1137 1146
41. R.A. Skidgel, X.P. Gao, and V. Brovkovych Nitric oxide stimulates macrophage inflammatory protein-2 expression in sepsis J Immunol 169 2002 2093 2101
42. M.R. Schaffer, U. Tantry, S.S. Gross, H.L. Wasserburg, and A. Barbul Nitric oxide regulates wound healing J Surg Res 63 1996 237 240
43. H.P. Shi, D. Most, D.T. Efron, M.B. Witte, and A. Barbul Supplemental L-arginine enhances wound healing in diabetic rats Wound Repair Regen 11 2003 198 203
44. S.P. Hussain, G. Trivers, and L. Gofseth Nitric oxide, a mediator of inflammation, suppresses tumorigenesis Cancer Res 64 2004 6849 6853
45. B.L. Hoffman, K. Takishima, M.R. Rosner, and C. Carlin Adenovirus and protein kinase C have distinct molecular requirements for regulating epidermal growth factor receptor trafficking J Cell Physiol 157 1993 535 543
46. H.V. Aposhian The use of DNA for gene therapy - the need, experimental approach, and implications Perspect Biol Med 14 1970 98 108
47. M. Lim, and P.L. Zeitlin Therapeutic strategies to correct malfunction of CFTR Paediatr Respir Rev 2 2001 159 164
48. L.A. Chandler, D.L. Gu, C. Ma, A.M. Gonzalez, J. Doukas, and T. Nguyen Matrix-enabled gene transfer for cutaneous wound repair Wound Repair Regen 8 2000 473 479
49. C.K. Byrnes, F.H. Khan, P.H. Nass, C. Hatoum, M.D. Duncan, and J.W. Harmon Success and limitations of a naked plasmid transfection protocol for keratinocyte growth factor-1 to enhance cutaneous wound healing Wound Repair Regen 9 2001 341 346
50. M.G. Jeschke, D.N. Herndon, W. Baer, R.E. Barrow, and K.W. Jauch Possibilities of non-viral gene transfer to improve cutaneous wound healing Curr Gene Ther 1 2001 267 278
51. W. Liu, B.J. Mehrara, G.S. Chin, M. Hsu, Z. Peled, and M.T. Longaker The use of newborn rats and an adenoviral gene delivery vector as a model system for wound-healing research Ann Plast Surg 44 2000 543 551
52. D.A. Muruve The innate immune response to adenovirus vectors Hum Gene Ther 15 2004 1157 1166
53. D.J. Margolis, T. Crombleholme, and M. Herlyn Clinical protocol: phase I trial to evaluate the safety of H5.020CMV.PDGF-B for the treatment of a diabetic insensate foot ulcer Wound Repair Regen 8 2000 480
54. Gene therapy clinical trials. Available from: URL: http://www.wiley.co. uk/wileychi/genmed/clinical